House Investigates Tenure Of FDA Medical Products Office Acting Head

In a letter to FDA Commissioner Hamburg, Energy and Commerce Committee leaders say public information discrepancies raised questions about Leona Brenner-Gati’s status and “the circumstances surrounding her resignation.”